±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 623  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

Ìì¿ÕÖ®ºÛ

½ð³æ (ÖøÃûдÊÖ)

Ò©ÎïС²©Ê¿

[ÇóÖú] ÇóÖúÒ»¶ÎÓ¢ÎÄ·­Ò룬ÔÚÏߵȡ£

How prevalent are co-crystals? American microscopist
Walter McCrone once famously said ¡®every compound has
different polymorphic forms, and that, in general, the
number of forms known for a given compound is proportional
to the time and money spent in research on that
compound¡¯ [22]. McCrone¡¯s words may yet also prove true
for co-crystals. At January 2012, only 3.1% of crystals
reported in the Cambridge Structural Database (CSD)
were known to be polymorphic (https://www.ccdc.cam.
ac.uk/products/csd/statistics/). This figure of course does
not take into account unpublished proprietary data on
pharmaceuticals, which are often the most studied compounds
in terms of their solid-state behaviour. By contrast,
approximately 15% contain water either in a co-crystal or
as part of a metal aquo complex. A perhaps truer representation
(albeit on a much smaller sample size) is given by
data from contract solid-form screening company SSCI,
reported in 2007 [20]. Of 245 polymorph screens on organic
compounds, 91% existed in more than one crystal form and
approximately half proved to have more than one pure
polymorph. A total of 64 sets of screening experiments
designed to reveal co-crystals indicated that approximately
61% of compounds studied formed co-crystals, whereas
approximately one-third of the compounds studied formed
hydrated or solvated forms. These numbers are consistent
with the proportions in the 1999 European Pharmacopeia
[23].
The behaviour of salt and non-salt forms proved to be
somewhat different. Although both types of compounds
existed as multiple solid forms approximately 91% of thetime,
non-salts showed a greater polymorphic tendency
(55% vs 39%), whereas salts, with their greater propensity
to hydrate ionic sites, exhibited a significantly greater tendency
to form hydrates (48% vs 30%) (Figure 2). A recently
launched web resource, Hydrateweb.org, collated published
data on pharmaceuticals monographed in Pharmacopeia
Europa 6.2, 2012 and revealed that of 955 substances,
287 form hydrates (30.1%), with an overall 415 different
hydrated crystal forms. Interestingly, there seems to be a
statistically significant relationship between co-crystal
formation and crystallisation with multiple symmetryindependent
molecules (a kind of ¡®self-co-crystallisation¡¯).
For example, based on the unusual three independent
molecule structure of the antibacterial ornidazole, the existence
of co-crystal forms was predicted and a co-crystal with
dinitrobenzoic acid prepared experimentally shortly after
the discovery of a hydrate form [24,25].

» ²ÂÄãϲ»¶

Ñо¿Í¸ÁË£¬Äã¾Í¿ªÊ¼¶®ÁË
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xux730

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ...
Ìì¿ÕÖ®ºÛ: ½ð±Ò+100, ·­ÒëEPI+1, ¡ïÓаïÖú, лл 2013-10-05 13:14:54
¹²¾§ÌåÓжàÆÕ±é£¿ÃÀ¹úÏÔ΢¾µ×¨¼ÒWalter McCroneÔø¾­ÓÐÒ»¾äÃûÑÔ˵£º¡°Ã¿Ò»¸ö»¯ºÏÎï¾ßÓв»Í¬µÄ¶à̬ÐÎʽ£¬ÔÚÒ»°ãÇé¿öÏ£¬¶ÔÓÚÒ»¸ö¸ø¶¨»¯ºÏÎïµÄÐÎ̬¶àÑùÐÔÓ뻨ÔÚ¸ÃÑо¿»¯ºÏÎïµÄʱ¼äºÍ¾­·Ñ³ÉÕý±È¡° [22] ¡£McCroneµÄ»°Ò²ÊÊÓÃÓÚ¹²¾§ÌåÑо¿¡£2012Äê1Ô£¬ÔÚ½£ÇŽṹÊý¾Ý¿â£¨ CSD £©ÀïÖ»ÓÐ3.1£¥ÒѾ­±¨µÀµÄ¾§ÌåÊǶà̬µÄ£¨https://www.ccdc.cam. ac.uk/products/csd/statistics/£© ¡£µ±È»£¬Õâ¸öÊý×Ö²¢Ã»ÓмÆÈëδ¹«²¼µÄÒ©Î﹫˾µÄ˽Óеľ§ÌåÊý¾Ý£¬Ò©Î﹫˾×î¾­³£Ñо¿»¯ºÏÎïÔÚ¹Ì̬ʱµÄ±íÐÍ¡£Óë´ËÏà·´£¬Ô¼15£¥£¨µÄ»¯ºÏÎ°üº¬¹²¾§ÌåÖеÄË®»òÊǽðÊôË®ºÏÅäºÏÎïµÄÒ»²¿·Ö¡£Ò²Ðí¸üÕæÊµµÄ´ú±í£¨¾¡¹ÜÊÇÒ»¸ö¸üСµÄÑù±¾£©ÊÇÓÚ2007Ä걨µÀµÄÀ´×Ô¹Ì̬ÐÎʽɸѡ¹«Ë¾SSCIµÄÊý¾Ý [20]¡£¶ÔÓлú»¯ºÏÎïµÄ245¸ö¶àÐÎ̬ɸѡÖУ¬91£¥ÔÚÒ»¸öÒÔÉϵľ§ÌåÐÎʽ´æÔÚ£¬Ô¼Ò»°ë±»Ö¤Ã÷ÓÐÒ»¸öÒÔÉϵĴ¿¶à¾§ÐÎ̬¡£×ܹ²64×éÖ¼ÔÚ½Òʾ¹²¾§ÌåµÄɸѡʵÑé±íÃ÷Ô¼61£¥µÄ»¯ºÏÎïÐγɹ²¾§£¬¶øÔ¼Èý·ÖÖ®Ò»µÄ»¯ºÏÎïÐγÉË®ºÏÎï»òÈܼÁ»¯ÎïÐÎʽ¡£ÕâЩÊý×ÖÓë1999Äê°æµÄÅ·ÖÞÒ©µä[23] ÊÇÒ»Öµġ£
ÑκͷÇÑÎÐÎʽµÄ±íÐͱ»Ö¤Ã÷ÊÇÓÐËù²»Í¬µÄ¡£ËäÈ»ÕâÁ½ÖÖÀàÐÍ»¯ºÏÎïÔÂ91%×÷Ϊ¶à¸ö¹ÌÌåÐÎʽ´æÔÚ£¬·ÇÑαíÏÖ³ö½Ï´óµÄ¶à¾§Ð͵ÄÇãÏò£¨55£¥±È39£¥ £© £¬¶ø¸üÆ«°®Ë®ºÏÀë×ÓλµãµÄÑÎÏÔʾ¸ü´óµÄ¡¢¸üÏÔÖøµÄÐγÉË®ºÏÎïµÄÇ÷ÊÆ£¨48£¥±È30£¥ £© £¨Í¼2£© ¡£×î½üÍÆ³öµÄÍøÂç×ÊÔ´ Hydrateweb.org ÕûÀíÁË2012ÄêÅ·ÖÞÒ©µä£¨6.2°æ±¾£©ÒѾ­·¢±íµÄÊý¾Ý£¬·¢ÏÖÔÚ955ÖÖÎïÖÊÖУ¬ 287ÖÖÐγÉË®ºÏÎ30.1£¥£© £¬ÕûÌåÉÏÓÐ415ÖÖ²»Í¬µÄË®ºÏ½á¾§ÐÎ̬¡£ÓÐȤµÄÊÇ£¬¹²¾§ÌåÐγɺͶà¸ö¶ÀÁ¢ÓÚ¶Ô³ÆÐԵķÖ×ӽᾧ£¨Ò»ÖÖ¡°×Ô¹²½á¾§' £©Ö®¼äµÄ¹ØÏµËƺõÓÐÒ»¸öͳ¼ÆÑ§ÉϵÄÏÔÖøÐÔ¡£ÀýÈ磬ÔÚ²»Ñ°³£µÄÈý¸ö¶ÀÁ¢µÄ¿¹¾úÏõßò·Ö×ӽṹµÄ»ù´¡ÉÏ£¬¹²¾§ÌåÐÎʽ±»Ô¤²â´æÔÚ£¬ÔÚ·¢ÏÖË®ºÏÎïÐÎʽ[24,25]ºó²»¾Ã£¬ÔÚʵÑéÊÒÖÆ±¸ÁËÓë¶þÏõ»ù±½¼×ËáµÄ¹²¾§Ìå¡£
2Â¥2013-10-05 13:04:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Ìì¿ÕÖ®ºÛ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϹ¤³Ì302·ÖÇóµ÷¼Á +9 zyxÉϰ¶£¡ 2026-04-04 9/450 2026-04-05 22:08 by ×íÎÌwl
[¿¼ÑÐ] 301Çóµ÷¼Á +3 ϸ°ûÏà¹Øµ°°× 2026-04-03 3/150 2026-04-05 21:07 by ѧԱ8dgXkO
[¿¼ÑÐ] 358Çóµ÷¼Á +7 Çïgk 2026-04-04 7/350 2026-04-05 13:29 by huangmoli
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +8 ÏàÐűػá¹ââÍòÕ 2026-04-05 10/500 2026-04-05 12:19 by Hdyxbekcb
[¿¼ÑÐ] 070300»¯Ñ§Çóµ÷¼Á +17 С»ÆÑ¼±¦ 2026-03-30 17/850 2026-04-05 12:03 by Äþܰ¹þ¹þ
[¿¼ÑÐ] 323Çóµ÷¼Á +8 Àî¼ÑÀÖ1 2026-04-04 8/400 2026-04-04 22:26 by hemengdong
[¿¼ÑÐ] 359Çóµ÷¼Á +7 hhhhaaaa$ 2026-04-04 7/350 2026-04-04 18:49 by imissbao
[¿¼ÑÐ] 321Çóµ÷¼Á +13 ÈÏÕæÇóÉÏѧ 2026-04-02 13/650 2026-04-04 18:23 by macy2011
[¿¼ÑÐ] ÔõôɾÌû×Ó°¡ +3 ·ìêØ1000 2026-04-04 3/150 2026-04-04 14:20 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] 357Çóµ÷¼Á +13 1050389037 2026-04-03 13/650 2026-04-03 22:27 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 322Çóµ÷¼Á +6 FZAC123 2026-04-03 6/300 2026-04-03 22:23 by ¿ÆÑÐСר¼Ò
[¿¼ÑÐ] 292Çóµ÷¼Á +21 ÊÇåû×ÓÒ²ÊÇÑÐ×Ó 2026-03-30 22/1100 2026-04-03 21:44 by qlm5820
[¿¼ÑÐ] 285Çóµ÷¼Á +6 FZAC123 2026-03-30 6/300 2026-04-03 12:22 by xingguangj
[¿¼ÑÐ] ÍÁľˮÀû328·ÖÇóµ÷¼Á +6 ¼²·çÖª¾¢²Ý666 2026-04-02 6/300 2026-04-03 11:38 by znian
[¿¼ÑÐ] Ò»Ö¾Ô¸Öйú¿ÆÑ§Ôº´óѧ265Çóµ÷¼Á +9 Ìñµ­ye 2026-03-31 10/500 2026-04-03 11:10 by txp1986
[¿¼ÑÐ] 338Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄÜÔ´¶¯Á¦£¬ÍâÓïÊÇÈÕÓï203 +5 zzz£¬£¬r 2026-04-02 5/250 2026-04-03 09:45 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 312Çóµ÷¼Á +4 ÉÞÔÂÉ« 2026-04-02 5/250 2026-04-03 08:21 by fangshan711
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©Ê¦·¶´óѧ¼ÆËã»úר˶£¬³õÊÔ373£¬Áù¼¶Í¨¹ý£¬ +3 ¼ÆËã»ú×·ÃÎÈË 2026-04-01 3/150 2026-04-02 07:57 by fxue1114
[¿¼ÑÐ] 379Çóµ÷¼Á +3 ?¿à¹Ï²»¿à 2026-04-01 3/150 2026-04-01 20:09 by ÄºÔÆÇ庮
[¿¼ÑÐ] Çóµ÷¼Á +4 DADA¹Ö 2026-03-31 4/200 2026-04-01 14:30 by ZXlzxl0425
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û